antimicrobial peptide ll-37 has been considered as a potential alternative to conventional antibiotics - LL-37 peptidebenefits LL-37 peptide plays an important role in the first line of defense Antimicrobial Peptide LL-37: A Multifaceted Component of Innate Immunity

LL-37 peptidebuy The human antimicrobial peptide LL-37 stands as a critical player in the body's innate immune system, functioning as a first line of defense against a broad spectrum of pathogens. This 37-amino acid peptide, belonging to the cathelicidin family, has garnered significant attention for its potent antimicrobial effects, offering potential alternatives to conventional antibiotics, particularly against antibiotic-resistant strains. Beyond its direct antimicrobial actions, LL-37 exhibits multifaceted roles, including immune modulation, inflammation regulation, and wound healing, underscoring its importance in maintaining host defense and tissue homeostasisThe Human LL-37(17-29) antimicrobial peptide reveals a ....

The Broad-Spectrum Antimicrobial Power of LL-37

LL-37's primary function is its ability to combat a wide array of microorganisms. It effectively targets bacteria, fungi, and viruses, demonstrating potent activity against both Gram-positive and Gram-negative bacteria.作者：YP Di·2020·被引用次数：139—Notably, LL37is in clinical trials for leg ulcer and melanoma, D2A21 for burn wound infections, LTX-109 for MRSA skin infections, NP213 for ... Notably, LL-37 has shown significant efficacy against challenging multidrug-resistant bacterial strains, such as *SThe Naturally Occurring Host Defense Peptide, LL-37, and .... aureus* biofilms, and even intracellular pathogens. Its mechanism of action often involves disrupting microbial membranes, leading to cell death. This broad spectrum of activity makes LL-37 a promising candidate for therapeutic applications, especially in the face of rising antimicrobial resistance.

Beyond Antimicrobial Action: LL-37's Immunomodulatory Roles

While its antimicrobial capabilities are well-established, LL-37 is far more than just a bactericidal agent. It acts as a potent immune modulator, influencing various cellular processes that contribute to the overall immune response. LL-37 can regulate inflammation by inhibiting the stimulation of immune cells by bacterial components like lipopolysaccharide (LPS). It also plays a role in inducing the expression of inflammatory genes, such as adhesion molecules and chemokines, which are vital for recruiting immune cells to sites of infection or injury. Furthermore, research suggests LL-37 is involved in wound healing, promoting tissue repair and regeneration. Its involvement extends to anticancer activities, with studies indicating it can impede tumor growth by inducing apoptosis in cancer cells.

LL-37: Structure, Origin, and Family

LL-37 is the sole human member of the cathelicidin family of antimicrobial peptidesStructure and organization of the human antimicrobial .... It is derived from the C-terminal region of the human cationic antimicrobial protein 18 (hCAP18).LL-37, also known ashCAP18, is a syntheticpeptidederived from the C-terminal region of the human cationicantimicrobialprotein (hCAP). This 37-residue peptide is characterized by its amphipathic alpha-helical structure, which is crucial for its interaction with microbial membranes.Cationic Antimicrobial Peptide LL-37 Is Effective against both ... Under physiological conditions, LL-37 carries a net positive charge, facilitating its accumulation on negatively charged bacterial surfaces as a preliminary step in its antimicrobial action. Its presence is widespread throughout the body, found in various tissues and bodily fluids, highlighting its systemic role in host defense.LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin ...

Therapeutic Potential and Future Directions

The diverse biological activities of LL-37, coupled with its potent antimicrobial effects against resistant pathogens, position it as a molecule of significant therapeutic interest. It is already being explored in clinical trials for conditions such as leg ulcers and melanoma. The development of LL-37-based therapies could offer novel strategies for treating infections that are currently difficult to manage with conventional antibiotics. Research continues to unravel the full spectrum of LL-37's functions, including its potential as an antiviral, antifungal, and even anti-inflammatory agent, paving the way for innovative treatments across a range of diseases.